Finally, H19 is upregulated in multiple types of cancer, including gastric cancer, colorectal cancer, breast cancer, ovarian cancer, and glioma, and also correlates with poor prognosis in these cancers [78–82]. This evidence concerns the gene H19 and central nervous system cancer.